Große, K.
Ohm, D.
Würstle, S. http://orcid.org/0000-0003-0787-3894
Brozat, J. F.
Schmid, R. M.
Trautwein, C.
Stallmach, A. http://orcid.org/0000-0002-6101-5244
Bruns, T. http://orcid.org/0000-0002-5576-6914
Reuken, Philipp A. http://orcid.org/0000-0002-7696-475X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1382 Project ID 403114013/B07)
Friedrich-Schiller-Universität Jena
Article History
Received: 7 August 2021
Accepted: 25 October 2021
First Online: 15 November 2021
Competing interests
: Outside the submitted work, T.B. has received honoraria from Intercept Pharmaceuticals, Falk Foundation, AbbVie, CSL Behring, Merck, and Norgine, and travel expenses from Gilead. A.S. obtained consulting fees from Abbvie, Amgen, Astellas, Biogen, Celltrion, Consal, CSL Behring, Galapagos, Gilead, Institut Allergosan, Janssen, MSD, Norgine, Pfizer Pharma, Roche, Shire and Takeda, lecture fees and travel support from Abbvie, Astellas, Celltrion, Falk Foundation, Ferring, Janssen, MSD, Recordati Pharma, and Takeda, and research support from Abbvie and Celltrion. P.A.R. received lecture and consulting fees from CSL Behring, Boston Scientific and Dr. Wilmar Schwabe and travel grants from Bayer and Merz Pharma. The other authors report no potential conflicts of interest relevant to the manuscript.